Litigation Details for Supernus Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2021)
✉ Email this page to a colleague
Supernus Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-09-10 |
| Court | District Court, D. Delaware | Date Terminated | 2023-11-13 |
| Cause | 28:1338 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 10,314,790; 8,298,576; 8,298,580; 8,663,683; 8,877,248; 8,889,191; 8,992,989; 9,549,940; 9,555,004; 9,622,983 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Supernus Pharmaceuticals, Inc. v. Lupin Limited
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Supernus Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-09-10 | 1 | Complaint | and 10,314,790 (“the ’790 patent”) attached hereto as Exhibits A–J (collectively, “the patents in suit… United States Patent Nos. 8,298,576 (“the ’576 patent”), 8,298,580 (“the ’580 patent”), 8,663,683 (“…(“the ’683 patent”), 8,877,248 (“the ’248 patent”), 8,889,191 (“the ’191 patent”), 8,992,989 (“the ’989…’989 patent”), 9,549,940 (“the ’940 patent”), 9,555,004 (“the ’004 patent”), 9,622,983 (“the ’983 patent… ’683 patent, claims 2-12, 15- 17, and 18-20 of the ’248 patent, claims 2-24 of the ’191 patent, claims | External link to document |
| 2023-04-05 | 112 | Order - -Memorandum and Order | U.S. Patent No. 9,622,983 (“the ’983 Patent”) and U.S. Patent No. 10,314,790 (“the ’790 Patent”) on January… four patents: U.S. Patent Nos. 8,992,989, 9,549,940, 9,622,983, and 10,314,790. …of U.S. Patent No. 8,992,989 (“the ’989 Patent”), U.S. Patent No. 9,549,940 (“the ’940 Patent”), U.S.…989 Patent, claims 14 & 18; ’940 Patent, claims 14 & 18; ’983 Patent, claims…banc). 4 (U.S. Patent No. 8,298,576 (“the ’576 Patent”)). 5 (E.g., ’790 Patent at 2:66-3:11, 6: | External link to document |
| 2021-09-10 | 3 | ANDA Form | 2021. Date of Expiration of Patent: 11/16/2027 for all patents except 8,298,576 4/4/2028.Thirty Month Stay… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 13 November 2023 1:21-cv-01293 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-09-10 | 4 | Patent/Trademark Report to Commissioner of Patents | 8,992,989 ; 9,549,940 ; 9,555,004 ; 9,622,983 ; 10,314,790 . (srs) (Entered: 09/13/2021) 10 September… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,298,576 ; 8,… 13 November 2023 1:21-cv-01293 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
